Gang Deng Selected Research

harmalol

6/2019

Subchronic toxicity and concomitant toxicokinetics of long-term oral administration of total alkaloid extracts from seeds of Peganum harmala Linn: A 28-day study in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gang Deng Research Topics

Disease

43	Neoplasms (Cancer) 04/2022 - 09/2005
12	Glioma (Gliomas) 04/2022 - 01/2015
11	Neoplasm Metastasis (Metastasis) 06/2021 - 05/2005
9	Stroke (Strokes) 10/2022 - 06/2017
9	Compression Fractures (Compression Fracture) 02/2017 - 03/2008
8	Prostatic Neoplasms (Prostate Cancer) 07/2022 - 02/2006
7	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 01/2011
7	Ischemic Stroke 01/2022 - 01/2015
7	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 01/2017
6	Brain Neoplasms (Brain Tumor) 01/2022 - 03/2018
6	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 09/2015
5	Edema (Dropsy) 01/2019 - 09/2003
4	Memory Disorders (Memory Loss) 10/2019 - 01/2015
4	Ischemia 01/2019 - 06/2012
4	Liver Neoplasms (Liver Cancer) 01/2019 - 08/2011
4	Carcinoma (Carcinomatosis) 03/2018 - 05/2005
4	Cholangiocarcinoma 12/2016 - 01/2011
3	Urinary Bladder Neoplasms (Bladder Cancer) 06/2022 - 01/2017
3	Thrombocytopenia (Thrombopenia) 05/2022 - 10/2014
3	Brain Ischemia (Cerebral Ischemia) 01/2022 - 06/2017
3	COVID-19 01/2021 - 11/2020
3	Tremor (Tremors) 11/2020 - 04/2019
3	Breast Neoplasms (Breast Cancer) 01/2020 - 10/2019
3	Carcinogenesis 01/2020 - 11/2013
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 12/2016 - 01/2015
3	Aortic Dissection 06/2016 - 11/2012
3	Osteoporosis 09/2012 - 10/2011
3	Pathologic Constriction (Stenosis) 06/2012 - 02/2007
3	Squamous Cell Carcinoma of Head and Neck 03/2012 - 05/2005
2	Cerebral Hemorrhage 09/2022 - 02/2018
2	Hypertension (High Blood Pressure) 09/2022 - 11/2012
2	Nervous System Diseases (Neurological Disorders) 04/2022 - 01/2016
2	Reperfusion Injury 02/2022 - 01/2022
2	Myocardial Infarction 01/2022 - 02/2017
2	Infarction (Infarctions) 01/2021 - 01/2019
2	Multiple Sclerosis 01/2021 - 01/2018
2	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2019 - 05/2016
2	Brain Edema (Cerebral Edema) 02/2018 - 10/2016
2	Body Weight (Weight, Body) 02/2018 - 01/2018
2	Fibrosis (Cirrhosis) 02/2018 - 01/2013
2	Weight Loss (Weight Reduction) 01/2018 - 01/2016
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2017 - 04/2015
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 09/2017 - 04/2017

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2008
9	Pharmaceutical PreparationsIBA 10/2022 - 09/2015
9	Biomarkers (Surrogate Marker)IBA 04/2022 - 08/2011
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 02/2008
7	MicroRNAs (MicroRNA)IBA 01/2021 - 11/2013
5	Circular RNAIBA 01/2022 - 06/2018
5	AndrogensIBA 01/2021 - 02/2008
4	Peptides (Polypeptides)IBA 10/2022 - 08/2011
4	Biological ProductsIBA 04/2022 - 01/2018
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 12/2017
4	Indicators and Reagents (Reagents)IBA 01/2021 - 05/2005
4	AlkaloidsIBA 01/2021 - 01/2017
3	Betulinic AcidIBA 10/2022 - 01/2019
3	AntioxidantsIBA 10/2022 - 01/2018
3	Temozolomide (Temodar)FDA LinkGeneric 01/2022 - 02/2020
3	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2022 - 09/2015
3	Harmine (Telepathine)IBA 01/2021 - 01/2018
3	Carbolines (Beta-Carbolines)IBA 01/2021 - 01/2017
3	HarmalineIBA 01/2021 - 01/2018
3	Neurotransmitter Agents (Neurotransmitter)IBA 11/2020 - 01/2018
3	CateninsIBA 01/2020 - 12/2016
3	Therapeutic UsesIBA 10/2019 - 01/2018
3	Scopolamine (Hyoscine)FDA Link 10/2019 - 01/2018
3	Glyburide (Glibenclamide)FDA LinkGeneric 01/2019 - 01/2018
3	Emodin (Archin)IBA 02/2018 - 09/2015
3	CholesterolIBA 04/2017 - 01/2008
3	Polymethyl Methacrylate (Sol)IBA 02/2012 - 03/2008
3	Messenger RNA (mRNA)IBA 11/2008 - 02/2008
2	Glucose (Dextrose)FDA LinkGeneric 09/2022 - 09/2015
2	PolyphenolsIBA 01/2022 - 02/2017
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2022 - 02/2018
2	icariinIBA 01/2022 - 11/2019
2	Histones (Histone)IBA 01/2022 - 01/2021
2	Hematoxylin (Haematoxylon)IBA 01/2022 - 02/2018
2	AngiopoietinsIBA 01/2021 - 02/2018
2	AutoantibodiesIBA 01/2021 - 01/2021
2	AntibodiesIBA 01/2021 - 09/2015
2	Antineoplastic Agents (Antineoplastics)IBA 01/2020 - 03/2018
2	AcetylcholinesteraseIBA 10/2019 - 01/2018
2	Cholinergic Agents (Cholinergics)IBA 10/2019 - 01/2018
2	3-deoxyvasicineIBA 10/2019 - 05/2019
2	Cholinesterase Inhibitors (Anticholinesterases)IBA 05/2019 - 10/2018
2	AlbuminsIBA 01/2019 - 01/2013
2	EnzymesIBA 05/2018 - 01/2013
2	Metformin (Glucophage)FDA LinkGeneric 01/2018 - 01/2016
2	Inosine Triphosphate (ITP)IBA 09/2017 - 04/2017

Therapy/Procedure

14	Therapeutics 02/2022 - 01/2008
11	Vertebroplasty 02/2017 - 03/2008
10	Drug Therapy (Chemotherapy) 06/2022 - 09/2014
7	Stents 11/2021 - 02/2007
4	Intravenous Administration 10/2022 - 01/2019
4	Immunotherapy 01/2021 - 09/2015
3	Endovascular Aneurysm Repair 06/2016 - 11/2012
3	Lasers (Laser) 04/2016 - 01/2015
2	Platelet Transfusion (Blood Platelet Transfusions) 05/2022 - 10/2014
2	Combination Drug Therapy (Combination Chemotherapy) 10/2021 - 01/2020
2	Cell Transplantation 01/2021 - 02/2017